RELATED CONTENT
IBA (Ion Beam Applications S.A) announced the release of an exclusive feature that reduces the power consumption of IBA proton therapy 230 MeV isochronous cyclotron (C230) by more than 30 percent. This unique feature helps reduce the overall cost of proton therapy, making it ever more accessible to patients worldwide.
June 01, 2015 
IBA (Ion Beam Applications S.A.) announced the release of the StealthChamber for improved accuracy and efficiency in small field dosimetry with stereotactic radiosurgery and stereotactic body radiation therapy (SRS/SBRT).
May 26, 2015 
Dolphin Online Treatment Monitoring from IBA (Ion Beam Applications S.A.) is a transmission detector for safer patient care, improved treatment control and confidence fraction by fraction – until the last fraction delivered.
May 22, 2015 
IBA (Ion Beam Applications S.A., EURONEXT) announced the first clinical use of its Proteus Plus Universal Beam Triggering Interface (UBTI), a new application in the administration of proton therapy. This interface can connect up to four different patient position monitoring and respiratory management systems to the IBA proton therapy system.
May 08, 2015 
Proton therapy has been on the rise in recent years, both in the United States and abroad, with more and more proton centers opening their doors to cancer patients around the globe. It provides an attractive alternative to conventional radiation therapy, as the directed beam more intensely attacks cancerous tissue while sparing surrounding healthy tissue and organs. In addition, radiation oncologists can control the depth to which the proton beam penetrates, and the beam will not travel any further, unlike traditional X-ray-based radiation therapy.
May 04, 2015 
Proton Partners International Limited announced the appointment of global partners in its plans to build three proton beam therapy centers in the U.K. Partner organizations will provide state-of-the-art clinical equipment and technology solutions to the company.
April 30, 2015 
Ion Beam Applications S.A. (IBA) and Pravida Bau GmBH announced an agreement to supply integrated single-room proton therapy solutions to customers in Europe.
April 29, 2015 IBA (Ion Beam Applications S.A.) announced that it has signed a formal contract with the University Medical Center Groningen (UMCG) to establish The Netherlands’ first proton therapy center in Groningen.
April 22, 2015 
IBA announced the release of its myQA global quality assurance platform. myQA offers full support throughout all quality assurance (QA) applications and provides the user access to their various software modules and data from one platform, anytime and anywhere.
April 03, 2015 
Ion Beam Applications S.A. (IBA) announced the successful expansion of IBA Academy on the Road “Small Field Dosimetry Workshop,” organized and hosted with Lung Center of the Philippines in Manila, and the Philippine Organization of Medical Physicists (POMP) on March 7.
March 24, 2015